SEGMENTS

12 Months Ended

Dec. 31, 2012

Segment Reporting [Abstract]

Segment

20. SEGMENTS

We have aggregated our operations into two reportable segments based upon product lines, manufacturing processes, marketing and management of our businesses: medical equipment and radiopharmaceuticals. Our business segments operate in the nuclear medicine industry. The Company’s medical equipment segment is currently generating all revenues and the majority of all expenses as the radiopharmaceuticals segment is still in the development phase.

We evaluate a segment’s performance based primarily upon operating income before corporate expenses.

Corporate assets consist primarily of cash but also include plant and equipment associated with our headquarters. These items (and income and expenses related to these items) are not allocated to the segments. Unallocated income/expenses include interest income, interest expense, debt extinguishment and refinancing costs and other (expense) income and certain expenses which are not considered related to either segment, but are instead considered general corporate expenses.

The following table represents sales, operating loss and total assets attributable to these business segments for the periods indicated (in thousands):

	Year Ended December 31,
	2012		2011
Total Sales:
Medical equipment	$	2,789	$	6,663
Radiopharmaceuticals		12		-
Total sales	$	2,801	$	6,663
Operating loss:
Medical equipment	$	3,690	$	3,775
Radiopharmaceuticals		1,026		396
Unallocated		6		221
Total operating loss	$	4,722	$	4,392

	December 31, 2012		December 31, 2011
Total assets:
Medical equipment	$	1,739		2,283
Radiopharmaceuticals		945		24
Unallocated		1		1
Total assets	$	2,685	$	2,308